GLP-1 receptor agonists (GLP-1RAs) effectively promote weight loss, reduce liver injury, and induce steatohepatitis resolution, though their impact on fibrosis, particularly in advanced disease, remains inconclusive [48, 49]. This evidence concerns the gene GLP1R and fibrosis.